Merck & Co Inc reported a 7.6per cent fall in second-quarter sales on Friday as a drop in visits to doctors’ offices because of the COVID-19 pandemic hurt sales of several important drugs.
Merck profit beats estimates on resilient Keytruda demand
- Advertisement -
